Three-phase bone scintigraphy can predict the analgesic efficacy of ketamine therapy in CRPS
The Clinical Journal of Pain Aug 15, 2018
Sorel M, et al. - The value of three-phase bone scintigraphy (TPBS) in assessing the efficacy of ketamine in relieving complex regional pain syndrome (CRPS) was assessed. They performed TPBS in 105 patients with unilateral, focal CRPS of type 1 before 5 days of ketamine infusions. The relative hyperfixation of the radioactive tracer in the limb region concerned by CRPS in phases 2 and 3 vs phase 1 of TPBS seemed to have a positive correlation with the analgesic efficacy of ketamine. This is the first study demonstrating the potential predictive value of TPBS regarding ketamine therapy outcome. In addition, the outcome support that the analgesic action of ketamine involves “central” mechanisms as well as “peripheral” mechanisms related to tissue inflammation and bone remodeling.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries